世界の組換えタンパク質市場2022年~2026年

【英語タイトル】Global Recombinant Proteins Market 2022-2026

Technavioが出版した調査資料(IRTNTR74151-22)・商品コード:IRTNTR74151-22
・発行会社(調査会社):Technavio
・発行日:2022年8月20日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、 ヨーロッパ、 アジア、 その他地域
・産業分野:食品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥345,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥552,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Technavio社発行の最新調査レポートでは、世界の組換えタンパク質市場規模が2022年から2026年まで年平均9.98%成長し、633.23百万ドルに達すると予測しています。当書では、組換えタンパク質の世界市場を総合的に調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(バイオテクノロジー研究、創薬・開発、バイオ医薬品製造、その他)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア、アメリカ、中国、ドイツ、イタリア、日本、カナダ)、推進要因・課題・動向、企業状況、企業分析などの項目をまとめています。なお、当書に掲載されている企業情報には、Abcam plc、Airway Therapeutics Inc.、Amgen Inc.、Aviva Systems Biology Corp.、Bio Rad Laboratories Inc.、Bio Techne Corp.、BPS Bioscience Inc.、Elabscience Biotechnology Inc.、Enzo Biochem Inc.、GenScript Biotech Corp.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の組換えタンパク質市場規模:用途別
- バイオテクノロジー研究用組換えタンパク質の市場規模2021-2026
- 創薬・開発用組換えタンパク質の市場規模2021-2026
- バイオ医薬品製造用組換えタンパク質の市場規模2021-2026
- その他用途の市場規模2021-2026
・顧客状況
・地域別状況
- 北米の組換えタンパク質市場規模2021-2026
- ヨーロッパの組換えタンパク質市場規模2021-2026
- アジアの組換えタンパク質市場規模2021-2026
- アメリカの組換えタンパク質市場規模2021-2026
- 中国の組換えタンパク質市場規模2021-2026
- ドイツの組換えタンパク質市場規模2021-2026
- イタリアの組換えタンパク質市場規模2021-2026
- 日本の組換えタンパク質市場規模2021-2026
- カナダの組換えタンパク質市場規模2021-2026
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。
❖ レポートの概要 ❖

Global Recombinant Proteins Market 2022-2026

Technavio has been monitoring the recombinant proteins market and it is poised to grow by $ 633.23 mn during 2022-2026, accelerating at a CAGR of 9.98% during the forecast period. Our report on the recombinant proteins market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in chronic diseases, a rising inclination toward biologics and biosimilars, and technological advancements in the production of recombinant proteins.

The recombinant proteins market analysis includes the application segment and geographic landscape.
Technavio’s recombinant proteins market is segmented as below:

By Application
• Biotechnology research
• Drug discovery and development
• Biopharmaceutical production
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in collaborations and strategic alliances by vendors as one of the prime reasons driving the recombinant proteins market growth during the next few years. Also, increased expenditure on r and d and growing opportunities from emerging economies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the recombinant proteins market covers the following areas:
• Recombinant proteins market sizing
• Recombinant proteins market forecast
• Recombinant proteins market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading recombinant proteins market vendors that include Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Bio Techne Corp., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., GigaGen Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi, Sino Biological Inc., and Thermo Fisher Scientific Inc. Also, the recombinant proteins market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application – Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 Biotechnology research – Market size and forecast 2021-2026
o Exhibit 28: Chart on Biotechnology research – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Biotechnology research – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Biotechnology research – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Biotechnology research – Year-over-year growth 2021-2026 (%)
o 5.4 Drug discovery and development – Market size and forecast 2021-2026
o Exhibit 32: Chart on Drug discovery and development – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Drug discovery and development – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Drug discovery and development – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Drug discovery and development – Year-over-year growth 2021-2026 (%)
o 5.5 Biopharmaceutical production – Market size and forecast 2021-2026
o Exhibit 36: Chart on Biopharmaceutical production – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Biopharmaceutical production – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Biopharmaceutical production – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Biopharmaceutical production – Year-over-year growth 2021-2026 (%)
o 5.6 Others – Market size and forecast 2021-2026
o Exhibit 40: Chart on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others – Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others – Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Application
o Exhibit 44: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 50: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 66: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 China – Market size and forecast 2021-2026
o Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.9 Germany – Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.10 Italy – Market size and forecast 2021-2026
o Exhibit 78: Chart on Italy – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Italy – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Italy – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Italy – Year-over-year growth 2021-2026 (%)
o 7.11 Japan – Market size and forecast 2021-2026
o Exhibit 82: Chart on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Japan – Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Japan – Year-over-year growth 2021-2026 (%)
o 7.12 Canada – Market size and forecast 2021-2026
o Exhibit 86: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 87: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 88: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abcam plc
o Exhibit 97: Abcam plc – Overview
o Exhibit 98: Abcam plc – Product / Service
o Exhibit 99: Abcam plc – Key news
o Exhibit 100: Abcam plc – Key offerings
o 10.4 Amgen Inc.
o Exhibit 101: Amgen Inc. – Overview
o Exhibit 102: Amgen Inc. – Product / Service
o Exhibit 103: Amgen Inc. – Key offerings
o 10.5 Bio Rad Laboratories Inc.
o Exhibit 104: Bio Rad Laboratories Inc. – Overview
o Exhibit 105: Bio Rad Laboratories Inc. – Business segments
o Exhibit 106: Bio Rad Laboratories Inc. – Key news
o Exhibit 107: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 108: Bio Rad Laboratories Inc. – Segment focus
o 10.6 Enzo Biochem Inc.
o Exhibit 109: Enzo Biochem Inc. – Overview
o Exhibit 110: Enzo Biochem Inc. – Business segments
o Exhibit 111: Enzo Biochem Inc. – Key offerings
o Exhibit 112: Enzo Biochem Inc. – Segment focus
o 10.7 Merck KGaA
o Exhibit 113: Merck KGaA – Overview
o Exhibit 114: Merck KGaA – Business segments
o Exhibit 115: Merck KGaA – Key news
o Exhibit 116: Merck KGaA – Key offerings
o Exhibit 117: Merck KGaA – Segment focus
o 10.8 Novartis AG
o Exhibit 118: Novartis AG – Overview
o Exhibit 119: Novartis AG – Business segments
o Exhibit 120: Novartis AG – Key offerings
o Exhibit 121: Novartis AG – Segment focus
o 10.9 Novo Nordisk AS
o Exhibit 122: Novo Nordisk AS – Overview
o Exhibit 123: Novo Nordisk AS – Business segments
o Exhibit 124: Novo Nordisk AS – Key offerings
o Exhibit 125: Novo Nordisk AS – Segment focus
o 10.10 Sanofi
o Exhibit 126: Sanofi – Overview
o Exhibit 127: Sanofi – Business segments
o Exhibit 128: Sanofi – Key news
o Exhibit 129: Sanofi – Key offerings
o Exhibit 130: Sanofi – Segment focus
o 10.11 Sino Biological Inc.
o Exhibit 131: Sino Biological Inc. – Overview
o Exhibit 132: Sino Biological Inc. – Product / Service
o Exhibit 133: Sino Biological Inc. – Key offerings
o 10.12 Thermo Fisher Scientific Inc.
o Exhibit 134: Thermo Fisher Scientific Inc. – Overview
o Exhibit 135: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 136: Thermo Fisher Scientific Inc. – Key news
o Exhibit 137: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 138: Thermo Fisher Scientific Inc. – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 139: Inclusions checklist
o Exhibit 140: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 141: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 142: Research methodology
o Exhibit 143: Validation techniques employed for market sizing
o Exhibit 144: Information sources
o 11.5 List of abbreviations
o Exhibit 145: List of abbreviations
o investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Application – Market share 2021-2026 (%)
Exhibits25: Data Table on Application – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Biotechnology research – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Biotechnology research – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Biotechnology research – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Biotechnology research – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Drug discovery and development – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Drug discovery and development – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Drug discovery and development – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Drug discovery and development – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Biopharmaceutical production – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Biopharmaceutical production – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Biopharmaceutical production – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Biopharmaceutical production – Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others – Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Application ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Italy – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Italy – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Italy – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Italy – Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan – Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan – Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ million)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abcam plc – Overview
Exhibits98: Abcam plc – Product / Service
Exhibits99: Abcam plc – Key news
Exhibits100: Abcam plc – Key offerings
Exhibits101: Amgen Inc. – Overview
Exhibits102: Amgen Inc. – Product / Service
Exhibits103: Amgen Inc. – Key offerings
Exhibits104: Bio Rad Laboratories Inc. – Overview
Exhibits105: Bio Rad Laboratories Inc. – Business segments
Exhibits106: Bio Rad Laboratories Inc. – Key news
Exhibits107: Bio Rad Laboratories Inc. – Key offerings
Exhibits108: Bio Rad Laboratories Inc. – Segment focus
Exhibits109: Enzo Biochem Inc. – Overview
Exhibits110: Enzo Biochem Inc. – Business segments
Exhibits111: Enzo Biochem Inc. – Key offerings
Exhibits112: Enzo Biochem Inc. – Segment focus
Exhibits113: Merck KGaA – Overview
Exhibits114: Merck KGaA – Business segments
Exhibits115: Merck KGaA – Key news
Exhibits116: Merck KGaA – Key offerings
Exhibits117: Merck KGaA – Segment focus
Exhibits118: Novartis AG – Overview
Exhibits119: Novartis AG – Business segments
Exhibits120: Novartis AG – Key offerings
Exhibits121: Novartis AG – Segment focus
Exhibits122: Novo Nordisk AS – Overview
Exhibits123: Novo Nordisk AS – Business segments
Exhibits124: Novo Nordisk AS – Key offerings
Exhibits125: Novo Nordisk AS – Segment focus
Exhibits126: Sanofi – Overview
Exhibits127: Sanofi – Business segments
Exhibits128: Sanofi – Key news
Exhibits129: Sanofi – Key offerings
Exhibits130: Sanofi – Segment focus
Exhibits131: Sino Biological Inc. – Overview
Exhibits132: Sino Biological Inc. – Product / Service
Exhibits133: Sino Biological Inc. – Key offerings
Exhibits134: Thermo Fisher Scientific Inc. – Overview
Exhibits135: Thermo Fisher Scientific Inc. – Business segments
Exhibits136: Thermo Fisher Scientific Inc. – Key news
Exhibits137: Thermo Fisher Scientific Inc. – Key offerings
Exhibits138: Thermo Fisher Scientific Inc. – Segment focus
Exhibits139: Inclusions checklist
Exhibits140: Exclusions checklist
Exhibits141: Currency conversion rates for US$
Exhibits142: Research methodology
Exhibits143: Validation techniques employed for market sizing
Exhibits144: Information sources
Exhibits145: List of abbreviations



★調査レポート[世界の組換えタンパク質市場2022年~2026年] (コード:IRTNTR74151-22)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組換えタンパク質市場2022年~2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆